You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immuno therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Birmingham, Los Angeles, Baltimore (BMS-986242, Nivolumab)

Terminated
Has Results
  • Cancer
  • Birmingham, Alabama
  • +3 more
Aug 24, 2020

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Nivolumab
  • Relatlimab
  • Ciudad de Buenos Aires, Buenos Aires, Argentina
  • +74 more
Nov 11, 2022

Leukemia Trial in Worldwide (BMS-936564, Cytarabine)

Terminated
Has Results
  • Leukemia
  • Los Angeles, California
  • +37 more
Aug 18, 2021

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Nivolumab
  • +3 more
  • Los Angeles, California
  • +58 more
Dec 1, 2021

Tumors by Site Trial in Worldwide (Relatlimab, Nivolumab, BMS-986213)

Active, not recruiting
  • Neoplasms by Site
  • Relatlimab
  • +2 more
  • La Jolla, California
  • +52 more
Feb 10, 2022

Melanoma Trial in United States (Ipilimumab, Nivolumab)

Completed
Has Results
  • Melanoma
  • Duarte, California
  • +35 more
Sep 8, 2021

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I

Recruiting
  • Clinical Stage 0 Gastric Cancer AJCC v8
  • +27 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Solid Tumors Trial in Worldwide (BMS-986156, Nivolumab)

Completed
  • Solid Tumors
  • Birmingham, Alabama
  • +26 more
Dec 15, 2020

International Multicentric Study ARON-1

Recruiting
  • Metastatic Renal Cell Carcinoma (mRCC)
  • pembrolizumab plus axitinib
  • Macerata, Italy
    Ospedale di Macerata, UOC Oncologia
Aug 30, 2022

COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

Not yet recruiting
  • Follicular Lymphoma
  • Cellular immunity vs SARS-CoV-2
  • +6 more
  • Alessandria, IT, Italy
  • +13 more
Oct 10, 2023

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Advanced Solid Tumors, Advanced B-cell NHL Trial in Worldwide (Urelumab, Nivolumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Advanced B-cell NHL
  • Urelumab
  • Nivolumab
  • Palo Alto, California
  • +16 more
Sep 10, 2020

Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

Completed
Has Results
  • Brain Cancer
  • Birmingham, Alabama
  • +124 more
Mar 16, 2022

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
  • Adjuvant chemoradiotherapy
  • (no location specified)
Dec 19, 2022

Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Los Angeles, California
  • +62 more
Jun 18, 2021

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Immunotherapy in Locally Advanced or Oligometastatic NSCLC

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • induction therapy
  • Esslingen, Germany
    Klinikum Esslingen
Aug 15, 2022

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

fteR Acute iSchemic Stroke Treated With Endovascular Therapy

Not yet recruiting
  • Ischemic Stroke
  • Thrombectomy
  • Prospective patient
  • (no location specified)
Apr 21, 2022

Metastatic Renal Cell Carcinoma Trial in Ulyanovsk (SBRT)

Completed
  • Metastatic Renal Cell Carcinoma
  • SBRT
  • Ulyanovsk, Ulyanovsk Region, Russian Federation
    Ulyanovsk regional cancer center
Oct 18, 2019

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023